SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Recruiting · NCT05375643 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention) | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Site, digestive system disorder, digestive system neoplasm, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, neoplasm, thoracic cancer | Recruiting | Not applicable | 2026-09-16 | NCT05375643 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Nadine Jackson, MD, MPH | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Dana-Farber Cancer Institute at St. Elizabeth's Medical Center | Brighton | United States | 2 |
| Dana-Farber Cancer Instiute - Merrimack Valley | Methuen | United States | 2 |